【24h】

Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.

机译:使用平衡透析的变体研究药物与血浆蛋白的结合。

获取原文
获取原文并翻译 | 示例
           

摘要

The plasma protein binding of three model compounds was investigated using a variant of equilibrium dialysis, denoted comparative equilibrium dialysis (CED), and the results were compared with those obtained with ultrafiltration (UF). In CED, the buffer that the plasma is dialysed against in traditional equilibrium dialysis is replaced by, for example, plasma from other species. The CED method has the advantage that the unbound concentration (C(u)) does not need to be measured, which can be difficult for drugs with extremely small unbound fractions. Instead, the ratio of the total drug concentration (C(tot)) on either side of the dialysis membrane at equilibrium is a direct measure of the relative binding properties of the two plasma types. For the first model compound, having an unbound fraction (f(u)) of about 0.05% in human plasma, the time to reach equilibrium was too long (>/=40h) to make the CED technique feasible in practice. For the second model compound, the more weakly bound drug NAD-299 (with an unbound fraction of about 2% in human plasma), the CED equilibration times were considerably shortened (
机译:使用平衡透析的一种形式,称为比较平衡透析(CED),研究了三种模型化合物的血浆蛋白结合,并将结果与​​超滤(UF)获得的结果进行了比较。在CED中,血浆中传统平衡透析所针对的缓冲液被例如其他物种的血浆所代替。 CED方法的优点在于不需要测量未结合浓度(C(u)),这对于未结合分数极低的药物可能很困难。相反,处于平衡状态的透析膜两侧的总药物浓度之比(C(tot))是这两种血浆类型的相对结合特性的直接量度。对于第一种模型化合物,其在人血浆中的未结合分数(f(u))约为0.05%,达到平衡的时间太长(> / = 40h),无法在实践中使用CED技术。对于第二种模型化合物,结合更弱的药物NAD-299(在人血浆中的未结合部分约为2%),CED平衡时间大大缩短(

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号